InvestorsObserver gives Laboratory Corp. of America Holdings (LH) a strong valuation score of 82 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. LH currently holds a better value than 82% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.
LH gets a 82 Valuation Rank today. Find out what this means to you and get the rest of the rankings on LH!
LH has a trailing twelve month Price to Earnings (PE) ratio of 10.7. The historical average of roughly 15 shows a average value for LH stock as investors are paying fair share prices relative to the company's earnings. LH's average trailing PE ratio shows that the firm has been trading around its fair market value recently. Its trailing 12-month earnings per share (EPS) of 24.38 justifies the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings.
LH currently has a 12-month-forward-PE-to-Growth (PEG) ratio of 1.3. The market is currently overvaluing LH in relation to its projected growth due to the PEG ratio being above the fair market value of 1. LH's PEG comes from its forward price to earnings ratio being divided by its growth rate. Because PEG ratios include more fundamentals of a company's overall health with additional focus on the future, they are one of the most used valuation metrics by analysts.
